Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.9 USD | +2.79% | -1.53% | -1.43% |
02/04 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
29/03 | KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.43% | 18.91M | |
+30.71% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.67% | 330B | |
+3.70% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+8.26% | 168B |
- Stock Market
- Equities
- KALA Stock
- News KALA BIO, Inc.
- Kala Pharmaceuticals Changes Name to Kala Bio